Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04282187
What this trial is testing

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Who this might be right for
Acute Myeloid LeukemiaEssential ThrombocythemiaMyelodysplastic Syndrome+6 more
University of Washington 25
Testing effectiveness (Phase 2)Study completedNCT05600855
What this trial is testing

Prevention of Severe Acute Graft-versus-host Disease in Adult Patients Using a daGOAT Model

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 115
Large-scale testing (Phase 3)Ended earlyNCT01642563
What this trial is testing

Italian Platelet Technology Assessment Study

Who this might be right for
LeukemiaLymphoma
Centro Nazionale Sangue 456
Testing effectiveness (Phase 2)UnknownNCT01079013
What this trial is testing

Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Who this might be right for
Non Hodgkin LymphomaHodgkin Lymphoma
Sheba Medical Center 40
Large-scale testing (Phase 3)UnknownNCT03655145
What this trial is testing

HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyeloproliferative Syndromes+1 more
Assistance Publique - Hôpitaux de Paris 344
Testing effectiveness (Phase 2)Study completedNCT01646645
What this trial is testing

Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegalovirus
Memorial Sloan Kettering Cancer Center 58
Large-scale testing (Phase 3)UnknownNCT04951323
What this trial is testing

Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

Who this might be right for
Coronavirus Disease 2019 (Covid19)Hematopoietic Neoplasms
University of Liege 50
Not applicableActive Not RecruitingNCT03965429
What this trial is testing

Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Malignant Hemopathy
Institut Paoli-Calmettes 1,020
Not applicableUnknownNCT04099082
What this trial is testing

Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans

Who this might be right for
Allogeneic Hematopoietic Stem Cell RecipientsAcute Respiratory InfectionParainfluenza Virus (PIV)
Assistance Publique - Hôpitaux de Paris 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06438796
What this trial is testing

Blinatumomab Maintenance After Allo-HSCT

Who this might be right for
High Risk Acute Lymphoblastic Leukemia
Ruijin Hospital 59
Testing effectiveness (Phase 2)UnknownNCT05084027
What this trial is testing

Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

Who this might be right for
Hematologic MalignancyOlder PatientsAllogeneic Hematopoietic Stem Cell Transplantation
First Affiliated Hospital of Zhejiang University 50
Not applicableUnknownNCT05675826
What this trial is testing

The Impact of Donor COVID-19 Infection Status on the Recipient in Allo-HSCT

Who this might be right for
COVID-19Hematopoietic Stem Cell Transplantation
Chen Suning 40
Testing effectiveness (Phase 2)Looking for participantsNCT05126849
What this trial is testing

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression

Who this might be right for
Refractory Idiopathic Aplastic AnemiaHaploidentical Allogeneic Hematopoietic Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 31
Testing effectiveness (Phase 2)WithdrawnNCT00728585
What this trial is testing

Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant

Who this might be right for
Gastrointestinal MucositisMalignant Neoplasm
Children's Oncology Group
Testing effectiveness (Phase 2)Study completedNCT02661035
What this trial is testing

Allo HSCT Using RIC for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+15 more
Masonic Cancer Center, University of Minnesota 156
Not applicableStudy completedNCT06198517
What this trial is testing

Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT

Who this might be right for
MoxibustionHematopoietic Stem Cell TransplantationHemorrhagic Cystitis+1 more
Yi Zhang 303
Not applicableNot Yet RecruitingNCT07666568
What this trial is testing

Younger vs. Older Donors in Allo-HSCT: TTE

Who this might be right for
A Target Trial Emulation StudyDonor AgeALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
The First Affiliated Hospital of Soochow University 5,000
Testing effectiveness (Phase 2)Study completedNCT01093586
What this trial is testing

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+73 more
Case Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Looking for participantsNCT01174108
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

Who this might be right for
Severe Aplastic AnemiaMDS (Myelodysplastic Syndrome)
National Heart, Lung, and Blood Institute (NHLBI) 120
Testing effectiveness (Phase 2)Study completedNCT01244906
What this trial is testing

Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant

Who this might be right for
Hematologic Neoplasms
Northside Hospital, Inc. 26
Next Page